Improving malaria diagnosis decreased the waste of malaria drugs in patients who didn’t need them. Now, clinicians who don’t know what else is causing fever tend to overprescribe antibiotics, increasing the risk of drug resistance.
Professor David Schellenberg, Director of the ACT Consortium, discusses their work to improve the way artemisinin-based combination therapies are used to treat malaria, as well as the challenges they face working across 10 different countries.
Health workers may now benefit from training manuals to best use malaria rapid diagnostic tests (RDTs). The resource was developed during a clinical trial in Tanzania and the authors encourage other health settings to adapt them.
The World Health Organization recommends using malaria rapid diagnostic tests (RDTs) and prescribing antimalarials only to patients who have a positive test result. As programmes gear up to implement this practice, researchers have reviewed literature and provided guidance to help design policies.
Social scientists from the ACT Consortium released a compendium of guidance notes and templates to help international health researchers design, set up, run, analyse and monitor qualitative research in their studies.
A field handbook published by the World Health Organization (WHO) provides guidance on how to control malaria in countries affected by conflict and humanitarian disaster. Prof Mark Rowland and Dr Toby Leslie, who led malaria research in Afghanistan for the ACT Consortium, contributed to the manual.
As we wrap up the year, Professor David Schellenberg shares news of recent developments and plans for 2014 in the ACT Consortium.
Malaria deaths have declined by 45% globally since 2000 - thanks to prevention and control measures, political commitment and expanded funding. But improving access to diagnosis and treatment is still needed, according to this year’s World Malaria Report.
Approximately 3,700 delegates from almost 100 countries attended the 62nd annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Washington, DC.
Several African countries are heavily affected by both HIV/AIDS and malaria. The ACT Consortium is investigating how antimalarial and antiretroviral drugs interact when taken simultaneously.
Many people who visit health clinics with fever in malaria endemic areas do not have malaria, but they still receive antimalarial drugs. A new report from the World Health Organization makes recommendations on how to best manage non-malarial causes of fever.
Members of the ACT Consortium will present scientific sessions and posters at the Marriott Wardman Park, in Washington DC, United States. The conference takes place between 13 and 17 November 2013.
The MESA grants will support operational research on preventing the spread, or reintroduction, of malaria transmission between neighboring areas, or from hotspots and pockets of transmission.
The Director of the ACT Consortium talks about the concept of malaria eradication on The Lancet Global Health Blog after attending the 6th Pan-African Multilateral Initiative on Malaria conference (MIM) in Durban, South Africa.
The ACT Consortium hosted five symposium sessions at the 6th Multilateral Initiative on Malaria (MIM) Pan African Conference, which took place from 7-11 October in Durban, South Africa. The gathering happens once every four years and is used by international scientists to showcase their research, aimed to improve the control of malaria - a disease that kills around 660,000 people per year.